Tom Murphy

Read the latest stories and analysis from Tom Murphy.

Valeant pitches potential eye drug, research focus

Valeant pitches potential eye drug, research focus

Tom Murphy · September 25, 2014 12:28 pm

Drugstores, retailers dive deeper into vaccines

Drugstores, retailers dive deeper into vaccines

Tom Murphy · September 17, 2014 6:51 pm

Gilead to license generic version of Sovaldi

Gilead to license generic version of Sovaldi

Tom Murphy · September 15, 2014 2:04 pm

Dollar General goes hostile in bid for rival

Dollar General goes hostile in bid for rival

Tom Murphy · September 10, 2014 2:40 pm

Walgreen adds activist hedge fund founder to board

Walgreen adds activist hedge fund founder to board

Tom Murphy · September 8, 2014 2:25 pm

CVS changes name, stops tobacco sales early

CVS changes name, stops tobacco sales early

Tom Murphy · September 3, 2014 6:21 pm

3 ways insurers can discourage sick from enrolling

3 ways insurers can discourage sick from enrolling

Tom Murphy · August 27, 2014 7:09 pm

Medtronic spends $350M on another European deal

Medtronic spends $350M on another European deal

Tom Murphy · August 27, 2014 12:38 pm

NewLink Genetics: Ready to test Ebola vaccine

NewLink Genetics: Ready to test Ebola vaccine

Tom Murphy · August 14, 2014 8:24 pm

4 keys to appealing a rejected insurance claim

4 keys to appealing a rejected insurance claim

Tom Murphy · August 13, 2014 2:34 pm

Insurer WellPoint plans name change to Anthem

Insurer WellPoint plans name change to Anthem

Tom Murphy · August 13, 2014 1:54 pm

Walgreen turns down inversion to cut tax bill

Walgreen turns down inversion to cut tax bill

Tom Murphy · August 6, 2014 8:05 pm